0001140361-14-014872.txt : 20140331
0001140361-14-014872.hdr.sgml : 20140331
20140331182744
ACCESSION NUMBER: 0001140361-14-014872
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140327
FILED AS OF DATE: 20140331
DATE AS OF CHANGE: 20140331
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morton Andrew C.
CENTRAL INDEX KEY: 0001498511
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 14731752
MAIL ADDRESS:
STREET 1: C/O HANGER ORTHOPEDIC GROUP, INC.
STREET 2: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
4
1
doc1.xml
FORM 4
X0306
4
2014-03-27
0
0000722723
HANGER, INC.
HGR
0001498511
Morton Andrew C.
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
0
1
0
0
V.P.-Human Resources
Common Stock
2014-03-27
4
S
0
520
32.3758
D
20175
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares.
These shares were sold at a range of sale prices from $32.31 to $32.57. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Includes (i) unvested restricted shares totaling 2,064 shares of stock from an initial grant of 2,064 shares of restricted stock made on March 7, 2014; (ii) unvested restricted shares and fully vested shares totaling 3,513 shares of stock from an initial grant of 3,958 shares of restricted stock and performance shares made on March 11, 2013; (iii) unvested restricted shares and fully vested shares totaling 3,748 shares of stock from an initial grant of 5,000 shares of restricted stock made on March 7, 2012; (iv) unvested restricted shares and fully vested shares totaling 3,385 shares of stock from an initial grant of 4,900 shares of restricted stock made on March 25, 2011; and [continued in next footnote]
(v) unvested restricted shares and fully vested shares totaling 7,465 shares of stock from an initial grant of 12,000 shares of restricted stock made on June 21, 2010. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Andrew C. Morton
2014-03-31